Close
Nordic 9Nordic 9

Pephexia (private company)

Denmark pephexia.com
See something wrong or missing? Let us know
Offices:Copenhagen
Industry:BiotechHealth servicesPharma
Business model:B2B

Pephexia is a biotechnology company from Denmark working to discover and develop innovative peptide-based pharmacotherapies for the effective and convenient treatment of cachexia and related diseases.

Investors: we tracked 2 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 2.18M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Pephexia

Name Criteria
France AbolerIS Pharma
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden Athera
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden AttgeNO
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Denmark Oui
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
France PEP-Therapy
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom CardiaTec Biosciences
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Mable
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Denmark Breye Therapeutics
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Spain Gate2Brain
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Finland DelSiTech
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Top